NCT07642180 Combined Effects of Pelvic Floor Retraining and Hypopressive Exercises in Uterine Prolapse Outcomes
| NCT ID | NCT07642180 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Uterine Prolapse |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2025-04-02 |
| Primary Completion | 2026-06-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2025-04-02 with a primary completion date of 2026-06-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
One common pelvic floor condition, particularly in postpartum or later life, is uterine prolapse. It is caused by weak pelvic floor muscles and connective tissues and often presents with pain, urinary incontinence, and reduced quality of life. Although pelvic floor muscle training (PFMT) is commonly used, newer methods such as Hypopressive Exercises (HE) and Pelvic Floor Functional Movement Retraining (PFFMR) offer promising approaches. HE focuses on posture and breathing strategies to reduce intra-abdominal pressure, while PFFMR retrains pelvic stability and function through integrated movement patterns. This study aims to evaluate the combined effects of HE and PFFMR on pain, urogynecological symptoms, and quality of life in women with uterine prolapse, compared to single interventions. This randomized clinical trial will include 32 women aged 30-60 years with stage I-II uterine prolapse at Ganga Ram Hospital, Lahore. Participants will undergo an 8-week program with supervised sessions three times per week. Outcomes will be assessed using the Pelvic Floor Bother Questionnaire (PFBQ), Numeric Pain Rating Scale (NPRS), and Prolapse Quality of Life Questionnaire (P-QoL), and analyzed using SPSS version 25.0.
Eligibility Criteria
Inclusion Criteria: * Females aged 30-60 years. * Diagnosed with stage I and II uterine prolapse. * women with ≥1 parity * women who have had a vaginal delivery Exclusion Criteria: * Recent pelvic surgery (\<6 months). * Pregnancy or postpartum within 6 months. * Neurological conditions affecting muscle control. * Participation in pelvic floor rehab in the past 6 months.
Contact & Investigator
Zunaira Bilal
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07642180 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 60 Years, studying Uterine Prolapse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07642180 currently recruiting?
Yes, NCT07642180 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07642180 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07642180 clinical trial?
NCT07642180 is sponsored by Riphah International University. The principal investigator is Zunaira Bilal at Riphah International University. The trial plans to enroll 32 participants.